{"id":1030,"date":"2022-12-17T01:03:18","date_gmt":"2022-12-17T01:03:18","guid":{"rendered":"https:\/\/medicine.nus.edu.sg\/medphc\/?p=1030"},"modified":"2023-05-31T05:46:21","modified_gmt":"2023-05-31T05:46:21","slug":"ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon","status":"publish","type":"post","link":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/","title":{"rendered":"AI platform that suggests drug cocktail for patients with relapsed lymphoma to undergo clinical trial soon"},"content":{"rendered":"<p>In the near future, patients with relapsed lymphoma can likely enrol in a formal clinical trial that will personalise the most effective cocktail of drugs to treat their disease based on calculations done by an artificial intelligence (AI) platform. Led by Dr Anand Jeyasekharan and A\/Prof Edward Chow (Department of Pharmacology) from the NUS Centre for Cancer Research (N2CR) and Cancer Science Institute of Singapore, a study on 17 patients who had suffered multiple lymphoma relapses saw significant improvement in eight of them after they took a cocktail of medication recommended by the platform. Of these eight patients, five had their cancer completely eradicated.<\/p>\n<ul>\n<li><a href=\"https:\/\/www.straitstimes.com\/singapore\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\">More Details<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>In the near future, patients with relapsed lymphoma can likely enrol in a formal clinical trial that will personalise the most effective cocktail of drugs to treat their disease based on calculations done by an artificial intelligence (AI) platform. Led by Dr Anand Jeyasekharan and A\/Prof Edward Chow (Department of Pharmacology) from the NUS Centre [&hellip;]<\/p>\n","protected":false},"author":9339,"featured_media":1029,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[4],"tags":[],"class_list":["post-1030","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AI platform that suggests drug cocktail for patients with relapsed lymphoma to undergo clinical trial soon - Pharmacology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AI platform that suggests drug cocktail for patients with relapsed lymphoma to undergo clinical trial soon - Pharmacology\" \/>\n<meta property=\"og:description\" content=\"In the near future, patients with relapsed lymphoma can likely enrol in a formal clinical trial that will personalise the most effective cocktail of drugs to treat their disease based on calculations done by an artificial intelligence (AI) platform. Led by Dr Anand Jeyasekharan and A\/Prof Edward Chow (Department of Pharmacology) from the NUS Centre [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharmacology\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-17T01:03:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-31T05:46:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicine.nus.edu.sg\/medphc\/wp-content\/uploads\/sites\/33\/2023\/02\/QPOP.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"540\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Hock Meng, Alan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Hock Meng, Alan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/news\\\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/news\\\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\\\/\"},\"author\":{\"name\":\"Hock Meng, Alan\",\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/#\\\/schema\\\/person\\\/7d3c6eda1bb38ccc10654332cc8ddd5e\"},\"headline\":\"AI platform that suggests drug cocktail for patients with relapsed lymphoma to undergo clinical trial soon\",\"datePublished\":\"2022-12-17T01:03:18+00:00\",\"dateModified\":\"2023-05-31T05:46:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/news\\\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\\\/\"},\"wordCount\":123,\"publisher\":{\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/news\\\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/wp-content\\\/uploads\\\/sites\\\/33\\\/2023\\\/02\\\/QPOP.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/news\\\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\\\/\",\"url\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/news\\\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\\\/\",\"name\":\"AI platform that suggests drug cocktail for patients with relapsed lymphoma to undergo clinical trial soon - Pharmacology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/news\\\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/news\\\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/wp-content\\\/uploads\\\/sites\\\/33\\\/2023\\\/02\\\/QPOP.jpg\",\"datePublished\":\"2022-12-17T01:03:18+00:00\",\"dateModified\":\"2023-05-31T05:46:21+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/news\\\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/news\\\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\\\/#primaryimage\",\"url\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/wp-content\\\/uploads\\\/sites\\\/33\\\/2023\\\/02\\\/QPOP.jpg\",\"contentUrl\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/wp-content\\\/uploads\\\/sites\\\/33\\\/2023\\\/02\\\/QPOP.jpg\",\"width\":960,\"height\":540},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/#website\",\"url\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/\",\"name\":\"Pharmacology\",\"description\":\"Just another WordPress site\",\"publisher\":{\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/#organization\",\"name\":\"Pharmacology\",\"url\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/wp-content\\\/uploads\\\/sites\\\/33\\\/2022\\\/06\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/wp-content\\\/uploads\\\/sites\\\/33\\\/2022\\\/06\\\/logo.png\",\"width\":467,\"height\":69,\"caption\":\"Pharmacology\"},\"image\":{\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/medicine.nus.edu.sg\\\/medphc\\\/#\\\/schema\\\/person\\\/7d3c6eda1bb38ccc10654332cc8ddd5e\",\"name\":\"Hock Meng, Alan\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f75f2a4f0013130c31e3192db50cfd0db80b109f6cdfc23cd2e4527e66bb7429?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f75f2a4f0013130c31e3192db50cfd0db80b109f6cdfc23cd2e4527e66bb7429?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f75f2a4f0013130c31e3192db50cfd0db80b109f6cdfc23cd2e4527e66bb7429?s=96&d=mm&r=g\",\"caption\":\"Hock Meng, Alan\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AI platform that suggests drug cocktail for patients with relapsed lymphoma to undergo clinical trial soon - Pharmacology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/","og_locale":"en_US","og_type":"article","og_title":"AI platform that suggests drug cocktail for patients with relapsed lymphoma to undergo clinical trial soon - Pharmacology","og_description":"In the near future, patients with relapsed lymphoma can likely enrol in a formal clinical trial that will personalise the most effective cocktail of drugs to treat their disease based on calculations done by an artificial intelligence (AI) platform. Led by Dr Anand Jeyasekharan and A\/Prof Edward Chow (Department of Pharmacology) from the NUS Centre [&hellip;]","og_url":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/","og_site_name":"Pharmacology","article_published_time":"2022-12-17T01:03:18+00:00","article_modified_time":"2023-05-31T05:46:21+00:00","og_image":[{"width":960,"height":540,"url":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-content\/uploads\/sites\/33\/2023\/02\/QPOP.jpg","type":"image\/jpeg"}],"author":"Hock Meng, Alan","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Hock Meng, Alan","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/#article","isPartOf":{"@id":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/"},"author":{"name":"Hock Meng, Alan","@id":"https:\/\/medicine.nus.edu.sg\/medphc\/#\/schema\/person\/7d3c6eda1bb38ccc10654332cc8ddd5e"},"headline":"AI platform that suggests drug cocktail for patients with relapsed lymphoma to undergo clinical trial soon","datePublished":"2022-12-17T01:03:18+00:00","dateModified":"2023-05-31T05:46:21+00:00","mainEntityOfPage":{"@id":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/"},"wordCount":123,"publisher":{"@id":"https:\/\/medicine.nus.edu.sg\/medphc\/#organization"},"image":{"@id":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/#primaryimage"},"thumbnailUrl":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-content\/uploads\/sites\/33\/2023\/02\/QPOP.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/","url":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/","name":"AI platform that suggests drug cocktail for patients with relapsed lymphoma to undergo clinical trial soon - Pharmacology","isPartOf":{"@id":"https:\/\/medicine.nus.edu.sg\/medphc\/#website"},"primaryImageOfPage":{"@id":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/#primaryimage"},"image":{"@id":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/#primaryimage"},"thumbnailUrl":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-content\/uploads\/sites\/33\/2023\/02\/QPOP.jpg","datePublished":"2022-12-17T01:03:18+00:00","dateModified":"2023-05-31T05:46:21+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicine.nus.edu.sg\/medphc\/news\/ai-platform-that-suggests-drug-cocktail-for-patients-with-relapsed-lymphoma-to-undergo-clinical-trial-soon\/#primaryimage","url":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-content\/uploads\/sites\/33\/2023\/02\/QPOP.jpg","contentUrl":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-content\/uploads\/sites\/33\/2023\/02\/QPOP.jpg","width":960,"height":540},{"@type":"WebSite","@id":"https:\/\/medicine.nus.edu.sg\/medphc\/#website","url":"https:\/\/medicine.nus.edu.sg\/medphc\/","name":"Pharmacology","description":"Just another WordPress site","publisher":{"@id":"https:\/\/medicine.nus.edu.sg\/medphc\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicine.nus.edu.sg\/medphc\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medicine.nus.edu.sg\/medphc\/#organization","name":"Pharmacology","url":"https:\/\/medicine.nus.edu.sg\/medphc\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicine.nus.edu.sg\/medphc\/#\/schema\/logo\/image\/","url":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-content\/uploads\/sites\/33\/2022\/06\/logo.png","contentUrl":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-content\/uploads\/sites\/33\/2022\/06\/logo.png","width":467,"height":69,"caption":"Pharmacology"},"image":{"@id":"https:\/\/medicine.nus.edu.sg\/medphc\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/medicine.nus.edu.sg\/medphc\/#\/schema\/person\/7d3c6eda1bb38ccc10654332cc8ddd5e","name":"Hock Meng, Alan","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f75f2a4f0013130c31e3192db50cfd0db80b109f6cdfc23cd2e4527e66bb7429?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f75f2a4f0013130c31e3192db50cfd0db80b109f6cdfc23cd2e4527e66bb7429?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f75f2a4f0013130c31e3192db50cfd0db80b109f6cdfc23cd2e4527e66bb7429?s=96&d=mm&r=g","caption":"Hock Meng, Alan"}}]}},"_links":{"self":[{"href":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-json\/wp\/v2\/posts\/1030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-json\/wp\/v2\/users\/9339"}],"replies":[{"embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-json\/wp\/v2\/comments?post=1030"}],"version-history":[{"count":1,"href":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-json\/wp\/v2\/posts\/1030\/revisions"}],"predecessor-version":[{"id":1031,"href":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-json\/wp\/v2\/posts\/1030\/revisions\/1031"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-json\/wp\/v2\/media\/1029"}],"wp:attachment":[{"href":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-json\/wp\/v2\/media?parent=1030"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-json\/wp\/v2\/categories?post=1030"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicine.nus.edu.sg\/medphc\/wp-json\/wp\/v2\/tags?post=1030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}